论文部分内容阅读
目前,对原发性肝癌的诊断尚无特异性检验指标。据国外文献报导,测定血清铜兰蛋白的含量,有助于原发性肝癌的诊断。我们对59例原发性肝癌患者进行了血清钢兰蛋白的含量测定,报告如下: 一、材料和方法 1.材料来源:辽宁省肿瘤医院1987年至1988年经B型超声显像和~(125)I AFP火箭电泳确诊,未经治疗的原发性肝癌患者,男46例、女13例,年龄最大者75岁,最小者27岁。对照组40例为同期健康输血员,男30例、女10例。 2.试剂:铜兰蛋白抗血清试剂,上海生物制品研究所,批号8601。 3.方法:采用单向定量免疫扩散法。
At present, there is no specific test for the diagnosis of primary liver cancer. According to reports in foreign countries, the determination of serum galenin content is helpful for the diagnosis of primary liver cancer. We measured the serum level of ceruloplasmin in 59 patients with primary liver cancer and reported the following: I. Materials and methods 1. Source of material: Liaoning Province Cancer Hospital from 1987 to 1988 by B-type ultrasound imaging and ~ ( 125) I AFP rocket electrophoresis diagnosis, untreated patients with primary liver cancer, 46 males and 13 females, the oldest 75 years old, the youngest 27 years old. In the control group, 40 patients were healthy blood donors in the same period, 30 males and 10 females. 2. Reagents: ceruloplasmin antiserum reagent, Shanghai Institute of Biological Products, Lot 8601. 3. Methods: One-way quantitative immunodiffusion.